Top 89%
dans ce catalogue (1041 pratiques notées)
Les scores se concentrent dans le haut de l’échelle ; la position au sein du catalogue est donc souvent plus parlante que le chiffre seul.
Evidence of impact / measured public value1/3
Only descriptive pilot metrics are public (~110,000 people biometrically enrolled by March 2025 out of a 3.5 million target); no independent measurement of fraud reduction, cost savings or health-access gains has been published.
Transparency, fairness & accountability1/3
The fund's legal basis is public (Law n°19-2023) and its biometric launch was announced under the Prime Minister's patronage, but no audit of match accuracy, false-duplicate rates or data-protection safeguards has been released.
Transferability / demonstrated replication1/3
The ABIS was explicitly architected as multi-tenant so CAMU and CNSS share one deduplication engine, and the same vendor pattern (Innovatrics ABIS + Akieni integration) is documented as reusable across agencies, though replication beyond these two funds is not yet evidenced.
Scalability beyond pilot1/3
Enrolment has reached roughly 3% of CAMU's 3.5 million-person target after use, with coverage in only three cities (Brazzaville, Pointe-Noire, Oyo), so scale-up beyond the pilot is not yet demonstrated.
Governance, capability & sustainability1/3
A dedicated law and ministerial oversight underpin CAMU, and the biometric platform has a named systems integrator (Akieni/YAO Corp), but no independent regulator or public audit of the AI-driven deduplication process is documented.
Evidoria. L'ABIS biométrique multi-tenant de la CAMU/CNSS — la République du Congo dédoublonne l'enrôlement à l'assurance maladie universelle. ID persistant: da4c3c94-8e06-4a1e-a597-6aff2ea2f908.